Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community
Trial of Male Circumcision: HIV, STD and Behavioral Effects in Men, Women and the Community
Sponsor: Johns Hopkins Bloomberg School of Public Health
This PHASE3 trial investigates Bacterial Vaginosis and Chlamydia Infections and is currently ongoing. Johns Hopkins Bloomberg School of Public Health leads this study, which shows 6 recorded versions since 2003 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Jan 2021 — Oct 2021 [monthly]
Unknown Status PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE3
First recorded
Aug 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Johns Hopkins Bloomberg School of Public Health
- MRC/UVRI and LSHTM Uganda Research Unit
- Rakai Health Sciences Program
- Wawer, Maria J., M.D.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Kalisizo, Uganda